Highlights and Quick Summary
- Share Based Compensation of Revenue for the quarter ending June 30, 2023 was 31.67% (a 8.05% increase compared to previous quarter)
- Year-over-year quarterly Share Based Compensation of Revenue increased by 555.69%
- Annual Share Based Compensation of Revenue for 2022 was 12.74% (a -33.75% decrease from previous year)
- Annual Share Based Compensation of Revenue for 2021 was 19.23% (a 166.71% increase from previous year)
- Annual Share Based Compensation of Revenue for 2020 was 7.21% (a -14.27% decrease from previous year)
- Twelve month Share Based Compensation of Revenue ending June 30, 2023 was 12.47% (a 1.71% increase compared to previous quarter)
- Twelve month trailing Share Based Compensation of Revenue increased by 16.22% year-over-year
Trailing Share Based Compensation of Revenue for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| 12.47% | 12.26% | 12.74% | 10.73% |
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Share Based Compensation of Revenue of DURECT Corporation
Most recent Share Based Compensation of Revenueof DRRX including historical data for past 10 years.Interactive Chart of Share Based Compensation of Revenue of DURECT Corporation
DURECT Corporation Share Based Compensation of Revenue for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 31.67% | 29.31% | – | – | – |
| 2022 | 17.59% | 4.83% | 29.77% | 35.4% | 12.74% |
| 2021 | 8.54% | 30.16% | 30.83% | 31.74% | 19.23% |
| 2020 | 28.55% | 35.03% | 2.01% | 25.96% | 7.21% |
| 2019 | 4.44% | 7.89% | 10.61% | 10.58% | 8.41% |
| 2018 | 342.9% | 6.71% | 18.72% | 18.95% | 19.63% |
| 2017 | 3.46% | 3.38% | 13.04% | 14.56% | 5.3% |
| 2016 | 17.97% | 16.46% | 22.08% | 19.68% | 18.93% |
| 2015 | 13.43% | 14.59% | 14.05% | 13.62% | 13.91% |
| 2014 | 18.32% | 18.72% | 16.92% | 11.54% | 15.88% |
| 2013 | 19.03% | 27.44% | 21.72% | 22.75% | 22.35% |
| 2012 | 31.68% | – | – | – | 8.14% |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic